Trans-catheter closure of the native aortic valve with an Amplatzer® Occluder to treat progressive aortic regurgitation after implantation of a left-ventricular assist device

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 6, 2011, Pages

  Grohmann, Jochen ^a   Blanke, Philipp ^a   Benk, Christoph ^a   Schlensak, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Amplatzer Occluder; Interventional therapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

AGED; AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; DEMENTIA; DEVICE; DYSPNEA; FORWARD HEART FAILURE; HEART OUTPUT; HEMODYNAMICS; HEMOLYSIS; HUMAN; ISCHEMIC CARDIOMYOPATHY; KIDNEY FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; LUNG EDEMA; MALE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; FEASIBILITY STUDIES; HEART CATHETERIZATION; HEART-ASSIST DEVICES; HUMANS; MALE; SEPTAL OCCLUDER DEVICE; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 79955589149     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.01.036     Document Type: Article

References (10)

1. Rose A.G., Park S.J., Bank A.J., Miller L.W. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg 2000, 70:1270-1274.
2. Letsou G.V., Connelly J.H., Delgado R.M., Myers T.J., Gregoric I.D., Smart F.W., Frazier O.H. Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency?. J Heart Lung Transplant 2006, 25:395-399.
3. Pak S.W., Uriel N., Takayama H., Cappleman S., Song R., Colombo P.C., Charles S., Mancini D., Gillam L., Naka Y., Jorde U.P. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant 2010, 29:1172-1176.
4. Mudd J.O., Cuda J.D., Halushka M., Soderlund K.A., Conte J.V., Russell S.D. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant 2008, 27:1269-1274.
5. Bryant A.S., Holman W.L., Nanda N.C., Vengala S., Blood M.S., Pamboukian S.V., Kirklin J.K. Native aortic valve insufficiency in patients with left ventricular assist devices. Ann Thorac Surg 2006, 81:e6-8.
6. Park S.J., Liao K.K., Segurola R., Madhu K.P., Miller L.W. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). J Thorac Cardiovasc Surg 2004, 127:264-266.
7. Riede F.T., Kostelka M., Dahnert I. Transcatheter aortic valve closure to treat severe aortic regurgitation in a patient failing stage I palliation for hypoplastic left heart syndrome. Catheter Cardiovasc Interv 2009, 74:913-915.
8. Holzer R., Balzer D., Cao Q.L., Lock K., Hijazi Z.M. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004, 43:1257-1263.
9. Spence M.S., Thomson J.D., Weber N., Qureshi S.A. Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 2006, 67:663-667.
10. Heilmann C., Geisen U., Benk C., Berchtold-Herz M., Trummer G., Schlensak C., Zieger B., Beyersdorf F. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur J Cardiothorac Surg 2009, 36:580-584.